153.29
1.73%
2.61
Handel nachbörslich:
153.29
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
---|---|---|---|---|---|
2025-01-30 | $154.6 | $151.1 | $3.47 | 834,626.0 | +1.73% |
2025-01-29 | $153.3 | $149.1 | $4.26 | 781,082.0 | -0.02% |
2025-01-28 | $152.6 | $148.3 | $4.36 | 1,092,480.0 | +1.70% |
2025-01-27 | $151.5 | $147.2 | $4.33 | 1,384,327.0 | -0.36% |
2025-01-24 | $149.2 | $146.0 | $3.21 | 935,104.0 | +0.78% |
2025-01-23 | $148.7 | $146.0 | $2.72 | 700,048.0 | +0.56% |
2025-01-22 | $147.2 | $145.3 | $1.87 | 684,964.0 | +0.60% |
2025-01-21 | $146.3 | $143.5 | $2.79 | 1,164,688.0 | +1.83% |
2025-01-17 | $144.8 | $141.6 | $3.25 | 907,136.0 | +0.94% |
2025-01-16 | $143.5 | $140.7 | $2.77 | 752,543.0 | -0.45% |
2025-01-15 | $142.6 | $138.7 | $3.98 | 801,974.0 | +2.19% |
2025-01-14 | $144.2 | $139.4 | $4.85 | 978,728.0 | -2.46% |
2025-01-13 | $144.0 | $138.5 | $5.54 | 1,196,812.0 | +1.51% |
2025-01-10 | $142.8 | $137.5 | $5.34 | 1,097,574.0 | +1.58% |
2025-01-08 | $139.2 | $137.0 | $2.20 | 870,842.0 | +0.84% |
2025-01-07 | $139.4 | $136.8 | $2.59 | 925,580.0 | +0.51% |
2025-01-06 | $139.7 | $136.1 | $3.59 | 1,090,267.0 | -0.91% |
2025-01-03 | $139.5 | $137.2 | $2.35 | 734,610.0 | +0.17% |
2025-01-02 | $139.5 | $136.7 | $2.75 | 846,408.0 | +1.00% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Neurocrine Biosciences Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der NBIX-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Neurocrine Biosciences Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2025
Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
---|---|---|---|---|---|
2025-01 | $154.6 | $136.1 | $18.48 | 18,614,419.0 | +12.30% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2024
Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
---|---|---|---|---|---|
2024-12 | $140.0 | $125.2 | $14.79 | 18,782,921.0 | +8.13% |
2024-11 | $129.7 | $115.3 | $14.40 | 19,906,873.0 | +5.39% |
2024-10 | $131.3 | $111.0 | $20.30 | 19,443,578.0 | +4.38% |
2024-09 | $128.8 | $114.1 | $14.73 | 19,963,392.0 | -9.32% |
2024-08 | $158.0 | $119.8 | $38.22 | 21,829,501.0 | -10.25% |
2024-07 | $150.4 | $135.8 | $14.54 | 15,345,591.0 | +2.83% |
2024-06 | $141.5 | $129.3 | $12.16 | 16,164,088.0 | +1.67% |
2024-05 | $145.8 | $131.9 | $13.88 | 16,706,330.0 | -1.55% |
2024-04 | $145.0 | $130.1 | $14.87 | 16,621,593.0 | -0.28% |
2024-03 | $148.4 | $129.2 | $19.22 | 19,907,081.0 | +5.77% |
2024-02 | $143.2 | $128.0 | $15.16 | 18,185,535.0 | -6.70% |
2024-01 | $143.3 | $129.5 | $13.85 | 15,057,095.0 | +6.08% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2023
Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
---|---|---|---|---|---|
2023-12 | $133.6 | $115.4 | $18.25 | 16,643,453.0 | +13.01% |
2023-11 | $117.5 | $103.6 | $13.89 | 14,627,971.0 | +5.09% |
2023-10 | $116.5 | $106.0 | $10.53 | 13,719,886.0 | -1.39% |
2023-09 | $119.3 | $108.1 | $11.16 | 14,430,173.0 | +3.32% |
2023-08 | $109.9 | $99.98 | $9.94 | 15,712,459.0 | +6.87% |
2023-07 | $103.7 | $93.28 | $10.46 | 14,222,291.0 | +8.05% |
2023-06 | $99.98 | $89.43 | $10.55 | 16,597,089.0 | +5.33% |
2023-05 | $108.0 | $89.04 | $18.94 | 17,981,173.0 | -11.39% |
2023-04 | $105.2 | $99.12 | $6.10 | 11,027,326.0 | -0.18% |
2023-03 | $103.1 | $92.89 | $10.25 | 16,613,284.0 | -1.82% |
2023-02 | $111.1 | $99.77 | $11.33 | 17,405,347.0 | -7.06% |
2023-01 | $125.0 | $106.2 | $18.80 | 17,444,124.0 | -7.12% |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):